DrugDev signs up George Masoura as Vice President of Business Development
DrugDev has announced the appointment of George Masoura who has joined the company as Vice President, Business Development, Europe to support escalated adoption of DrugDev Spark, “the world’s first unified clinical operations suite.”
Masoura joins DrugDev to continue building relationships with European and ROW pharmaceutical companies as global demand for proven technology solutions increases – with especially strong interest in site selection and feasibility, site activation, LMS, site payments and eConsent.
With over 20 years’ experience in the pharmaceutical industry, Masoura brings a wealth of specialised knowledge and skills to DrugDev’s continued expansion of its European operations. His global perspective and track record in business acquisition gained from working with many of the leading eClinical market innovators combined with expertise in digital transformation, outsourcing, business performance improvement and data governance will play a vital role in DrugDev’s future growth.
“I’m joining DrugDev at an exciting time,” said Masoura. “DrugDev Spark is an advanced technology platform its unified approach brings a paradigm shift to organisations that want to gain better control and visibility over their trial activities. We’re leading a fundamental change in the way people think of clinical trials and how the sponsors engage with sites and patients. What attracted me most is the passion DrugDev has for the challenge of improving clinical research outcomes, the will and ability to meet it, and the element of empathy it brings to clinical development. I’m proud to be part of a company that has such a remarkable ability to bring together technology assets and a clear understanding and anticipation of market needs in Europe.”
Previously Masoura was Senior Business Development Director, Informatics, at Covance, where he led strategic sales and business development activities for the Xcellerate informatics platform. He also held senior sales and marketing positions at Eclinso, unithink, Medidata Solutions and CRF Health, among others. As an independent consultant, he specialised in business development activities to improve the operational efficiency of pharma companies through technology adoption and process modernisation.
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …
After more than two decades at the head of the company, it has emerged that …